Development of a drug-response modeling framework to identify cell line derived translational biomarkers that can predict treatment of Erlotinib or Sorafenib

Li, B., Shin, H., Glubekyan, G., Pustovalova, O., Nikolsky, Y., Hope, A., Bessarabova, M., & Schu, M. (2015). Development of a drug-response modeling framework to identify cell line derived translational biomarkers that can predict treatment of Erlotinib or Sorafenib. PLoS One.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

"Show Me the Energy Costs"
Article

Effectiveness of interventions for the remediation of lead-contaminated soil to prevent or reduce lead exposure-A systematic review
Article

Variation in estimates of heat-related mortality reduction due to tree cover in US cities
Article

Promoting reproducibility and increased collaboration in electric sector capacity expansion models with community benchmarking and intercomparison efforts